Dopamine metabolite levels in the vitreous of diabetic and non-diabetic humans
EXPERIMENTAL EYE RESEARCH(2020)
摘要
Animal studies suggest that the retinal dysfunction in diabetic subjects that precedes overt clinical vasculopathy may be due to a retinal dopamine deficit. We analyzed levels of dopamine (DA) and its primary metabolite, 3,4-dihydroxyphenylacetic acid (DOPAC), in the vitreous of diabetic and non-diabetic human subjects. Adult patients undergoing pars plana vitrectomy for non-hemorrhagic indications were prospectively recruited from the Emory Eye Center in Atlanta, GA. Vitreous samples were analyzed using high performance liquid chromatography (HPLC) to measure levels of DOPAC and DA in the vitreous specimens. Vitreous samples from 9 diabetic patients and 20 from non-diabetic patients were analyzed. No eyes had apparent diabetic retinopathy. Mean normalized DA concentration in vitreous of diabetic subjects was 0.76 +/- 0.12 pg/mu L vs. 0.73 +/- 0.08 pg/mu L in non-diabetic vitreous (p = 0.849). DOPAC concentration was 8.84 +/- 0.74 pg/mu L in vitreous of diabetic subjects vs. 9.22 +/- 0.56 pg/mu L in vitreous of non-diabetic subjects (p = 0.691). No difference was observed in the concentrations of DA and DOPAC in the vitreous of people without diabetes compared to those with diabetes without retinopathy.
更多查看译文
关键词
Dopamine,Diabetes,Diabetic retinopathy,Vitreous
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要